LONDON, March 28, 2017 /PRNewswire/ --
PharmaBoardroom today releases its new 56-page Healthcare & Life SciencesReview Ireland 2017.
This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power,
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on Ireland's healthcare and pharma sectors.
Featured topics include:
The report features in-depth interviews with:
"Ireland is actually the most efficient EU country in terms of innovation output"
Mark Ferguson, Science Foundation Ireland
"[Ireland has] proven that, given the opportunity, we will deliver. The pharma industry is not in Ireland by accident"
Noel Heaney, BMS Biologics
"There are so many clusters of expertise in the API, pharma, biopharma and medtech sectors and that is fantastic because it fosters talent development"
Gearoid McDermott, Amneal
"Within Europe, there is clear recognition that Ireland has a strong life sciences ecosystem. This translates into the European market: when these pharma companies need partners across Europe, they approach their Irish partners first"
Donal O'Callaghan, Callaghan Engineering
Click here to register and download the report.
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All